Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.clineuro.2021.106775 http://scihub22266oqcxt.onion/10.1016/j.clineuro.2021.106775 34175645!8222978!34175645     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Neurol+Neurosurg 2021 ; 207 (ä): 106775 Nephropedia Template TP {{tp|p=34175645|t=2021. Guillain-Barre syndrome as only manifestation of COVID-19 infection |pdf=|usr=}}{{34175645}} gab.com Text Guillain-Barre syndrome as only manifestation of COVID-19 infection JO: Clin Neurol Neurosurg http://www.kidney.de/pget.php?&tw=1&pmid=34175645 #FOAvip Post-infectious/immune mediated effects of COVID-19 infection include descriptions of Guillain-Barre syndrome (GBS) in patients usually with respiratory failure and after 1-2 weeks from the onset of viral illness. Asymptomatic cases for COVID-19 infection were rarely described. Herein, we studied a 62-year-old patient with progressive weakness of lower extremities, rapidly evolving to a severe, flaccid tetraplegia and dysphagia. Neurological symptoms weren't preceded by fever or pulmonary symptoms. Because of laboratory test abnormalities (thrombocytopenia, lymphocytopenia, high inflammation indexes), the patient underwent to nasopharyngeal swab, resulted positive for SARS-CoV-2 on RT-PCR assay; cerebrospinal fluid (CSF) was negative for SARS-CoV-2. The clinical (severe symmetric distal upper and lower limbs weakness, grade 0/5; decreased proprioceptive sensitivity and hypoesthesia involving the four limbs; loss of deep tendon reflexes), electrophysiological (prevailing axonal polyradiculoneuritis) and CSF features (albumino-cytological dissociation) disclosed the GBS diagnosis (level 1 of diagnostic certainty according to the Brighton criteria). The patient received plasma exchange and immunoglobulin, and, at 4 weeks after treatment and physical therapy, the patient had moderate improvement (weakness at lower and upper extremities was grade 2/5 and 3/5, respectively). Neurologists and clinicians should be aware of the possible link between neurological symptoms and COVID-19 infection, not only after viral prodrome and pulmonary symptoms, but also without COVID-19 symptoms. Twit Text FOAVip Guillain-Barre syndrome as only manifestation of COVID-19 infection ????Clin Neurol Neurosurg http://www.kidney.de/pget.php?&tw=1&pmid=34175645 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34175645 #FOAvip English Wikipedia <ref>{{Cite pmid|34175645}}</ref> Guillain-Barre syndrome as only manifestation of COVID-19 infection #MMPMID34175645 d'Orsi G; Sica S; Maiorano A; Melchionda D; Lalla A; Montemurro L; Sabetta A; Goffredo R; Lecce B; Fiore JR; Santantonio T; Avolio C Clin Neurol Neurosurg 2021[Aug]; 207 (ä): 106775 PMID34175645show ga Post-infectious/immune mediated effects of COVID-19 infection include descriptions of Guillain-Barre syndrome (GBS) in patients usually with respiratory failure and after 1-2 weeks from the onset of viral illness. Asymptomatic cases for COVID-19 infection were rarely described. Herein, we studied a 62-year-old patient with progressive weakness of lower extremities, rapidly evolving to a severe, flaccid tetraplegia and dysphagia. Neurological symptoms weren't preceded by fever or pulmonary symptoms. Because of laboratory test abnormalities (thrombocytopenia, lymphocytopenia, high inflammation indexes), the patient underwent to nasopharyngeal swab, resulted positive for SARS-CoV-2 on RT-PCR assay; cerebrospinal fluid (CSF) was negative for SARS-CoV-2. The clinical (severe symmetric distal upper and lower limbs weakness, grade 0/5; decreased proprioceptive sensitivity and hypoesthesia involving the four limbs; loss of deep tendon reflexes), electrophysiological (prevailing axonal polyradiculoneuritis) and CSF features (albumino-cytological dissociation) disclosed the GBS diagnosis (level 1 of diagnostic certainty according to the Brighton criteria). The patient received plasma exchange and immunoglobulin, and, at 4 weeks after treatment and physical therapy, the patient had moderate improvement (weakness at lower and upper extremities was grade 2/5 and 3/5, respectively). Neurologists and clinicians should be aware of the possible link between neurological symptoms and COVID-19 infection, not only after viral prodrome and pulmonary symptoms, but also without COVID-19 symptoms. |COVID-19/*complications/*diagnostic imaging/therapy[MESH] |Guillain-Barre Syndrome/*diagnostic imaging/*etiology/therapy[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH]Guillain-Barre syndrome as only manifestation of COVID-19 infection (epmc).pdf DeepDyve Pubget Overpricing